If you made any changes in Pure these will be visible here soon.

Personal profile

Research interests

Piotr joined the Department of Social and Policy Sciences as a Prize Fellow in March 2013. He previously worked as a Research Associate at the Social Science Applied to Healthcare Improvement Research (SAPPHIRE) Group at the Department of Health Sciences, University of Leicester.

Piotr earned his PhD in Sociology from the University of Cambridge (2007-2012). Prior to this, he did an MA in Sociology at the University of Warsaw (2002-2007).

Piotr’s research looks at decision-making mechanisms, especially in policy areas with important implications for public health. He is interested in how expert knowledge is generated, supplied, and utilised in the policy process. In analysing these themes, he considers complex relationships between public institutions, private economic actors, think-tanks and non-governmental organisations.

Research interests

  • Sociological theories of the state
  • Theories of the policy process
  • Governance of scientific expertise
  • Regulation of risk
  • Better regulation
  • Lobbying
  • Pharmaceuticals
  • Drug pricing and reimbursement
  • Health technology assessment
  • Postcommunist transition

Recent and current research projects

What can be learnt from the new pharmaceutical industry payment disclosures?, funding provided by the Swedish Research council FORTE

Research affiliations

Fingerprint Dive into the research topics where Piotr Ozieranski is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.


Research Output

Five years of pharmaceutical industry funding of patient organisations in Sweden: Cross-sectional study of companies, patient organisations and drugs

Mulinari, S., Vilhelmsson, A., Rickard, E. & Ozieranski, P., 24 Jun 2020, In : PLoS ONE. 15, 6, e0235021.

Research output: Contribution to journalArticle

Open Access

Alternative access schemes for pharmaceuticals in Europe: Towards an emerging typology

Löblová, O., Csanádi, M., Ozierański, P., Kaló, Z., King, L. & McKee, M., 1 Jul 2019, In : Health Policy. 123, 7, p. 630-634 5 p.

Research output: Contribution to journalArticle

Open Access
1 Citation (Scopus)
1 Downloads (Pure)

Analysis of Pharmaceutical Industry Payments to UK Health Care Organizations in 2015

Ozieranski, P., Csanadi, M., Rickard, E., Tchilingirian, J. & Mulinari, S., 21 Jun 2019, In : JAMA Network Open. 2, 6, p. 1-14 14 p., e196253.

Research output: Contribution to journalArticle

Open Access
3 Citations (Scopus)

Evaluating the transparency of pharmaceutical company disclosure of payments to patient organisations in the UK

Rickard, E., Ozieranski, P. & Mulinari, S., 1 Dec 2019, In : Health Policy. 123, 12, p. 1244-1250 7 p.

Research output: Contribution to journalArticle

Exposing drug industry funding of UK patient organisations

Ozieranski, P., Rickard, E. & Mulinari, S., 22 May 2019, In : British Medical Journal. 365, p. 1-9 9 p., I1806.

Research output: Contribution to journalArticle

Open Access
8 Citations (Scopus)


Underreporting of drug industry payments to patient organisations in the UK (2012-2016)

Ozieranski, P. (Creator), Csanadi, M. (Creator), Rickard, E. (Creator) & Mulinari, S. (Creator), University of Bath, 10 Jul 2020